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Abstract 
The study aimed at profiling the fatty acids in methylated n-hexane extract of Alstonia boonei leaf using Gas 
Chromatography coupled with Mass Spectrophotometer (GC-MS). The qualitative and quantitative evaluations 
of the oil extracted from the leaves revealed the fatty acids contents and presented a ω-6: ω-3 PUFA ratio of 2.77. 
Thus, these study revealed the various bioactive compounds in Alstonia boonei leaf n-hexane and inferred its 
utilization to effect pharmaceutically relevance. 
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Introduction 
Dietary fats and oils provide calories and essential fatty acids and are sources of fat- soluble vitamins. Certain 
types of fat, however can increase risk of chronic cardiovascular diseases that affect the heart, blood vessels, and 
brain. The type of fat that is consumed can have either positive or negative effects on risk of cardiovascular 
disease (CVD). Saturated fatty acids (SFA) and trans-fatty acids are generally considered as unhealthy; whereas, 
monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) are considered beneficial (USDA). 
The effect of dietary SFA on CVD is partially mediated by effects on blood lipids, in particular, increased total 
cholesterol, and low density lipoproteins (LDL) cholesterol. Elevated blood LDL cholesterol increases 
artherosclerotic lipid accumulation in blood vessels and is an intermediate marker of CVD progression. 
Therefore reduction in SFA intake has been a key component of dietary recommendations to reduce the risk of 
CVD (USDA). 
Upon consumption, the body converts alpha-linolenic acid (ALA), the primary Omega-3 fatty acid, to 
eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), these two types of omega-3 (ω-3) fatty acids 
are more readily used by the body. Researches indicate that omega-3 fatty acids reduce inflammation and help 
prevent certain chronic diseases like heart disease, stroke, arthritis, skin disorders, diabetes, high cholesterol, 
high blood pressure, breast, colon and prostate cancer. Linoleic Acid is the primary Omega-6 (ω-6) fatty acid. A 
person of good health and fit nutrition will convert linoleic acid into gamma linolenic acid (GLA), which will 
later be manufactured with EPA from the Omega-3 group into eicosanoids (the body’s cellular check and 
balance system.).  The ratio of omega-6 to omega-3 essential fatty acids have been shown to provide a clue about 
the health status of an individual. 
Plants produce a diverse range of bioactive molecules, making them a rich source of different types of 
medicines, among those plants whose parts have found wide application in phytotherapy is Alstonia boonei De 
Wild, a large evergreen tree belonging to the family Apocynaceae. It is one of the widely used medicinal plants 
in Africa and beyond. It grows up to an altitude of about 45m and 1.2m diameter. It is distributed throughout the 
tropics and the rain forest of west and Central Africa Akinloye et al. (2013). Almost all the plant parts viz. leaves, 
stem bark; root and inflorescences have been used and are further under investigative study. Specifically, the 
stem bark, has been reported to possess anti-inflammatory, analgesic and antipyretic activities, antifungal, 
antibacterial, antiviral, antithrombosis, anti-tumor and antioxidant activities (Akinmoladun et al., 2007). Raji and 
Akinsomisoye (2005) reported that the methanolic extract of A. boonei has reversible antifertility effects in male 
rats. The stem bark is commonly used in treating malaria, toothache and rheumatism (Akinmoladun et al., 2007). 
The chloroform and methanol extracts from the roots showed activity against Staphylococcuc aureus, Bacillus 
subtilis, Escherichia coli and Pseudomonas aeruginosa (Deepthi et al., 2008). The hypoglyceamic activity of 
stem bark aqueous extract of A. boonei was also reported by Akinloye et al. (2013). Thus as the plant possesses 
immense medicinal properties, the aim of the present work was to identify the compounds present in the 
chloroform-methanol-hexane extract of Alstonia boonei leaf by Gas Chromatography coupled Mass spectrum 
(GC-MS) analysis. 
 
Materials and method  
Plant collection  
The leaves of Alstonia boonei, were collected in bulk from Egun farm settlement, Ifaki-Ekiti, Ekiti State, and 
authenticated at the Department of Crop, Soil and Pest Management, School of Agriculture and Agricultural 
Technology, Federal University of Technology, Akure. After authentication, the leaves were washed under 
running tap water to remove adhering dirt followed by rinsing with distilled water, air dried in shadow and 
grinded by mixer grinder.  
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Lipid Extraction 
Lipid from the dried Alstonia boonei leaves sample was extracted using AOAC (1990) with little modification. 
300g of dried and grounded leaves was dissolved in chloroform (300ml) in a test tube fitted with a condenser, 
and 1% sulfuric acid in methanol (150ml) was added, mixture was vortexed for 2 hours and 50ml of sodium 
chloride solution (5% w/v) was later added and the required esters was extracted with 50ml of hexane. Pasteur 
pipettes was then used to separate the layers. The hexane layer was washed with 50ml of 2% w/v potassium 
bicarbonate solution and dried over anhydrous sodium sulfate. The solution was then harvested to remove the 
drying agent, and the solvent removed under reduced pressure in a rotary film evaporator. The lipid extract was 
stored in an air -tight container in a desiccator at 4oC until when needed. The lipid extract was further methylated 
using standard laboratory protocol. 50mg of the extracted fat content of the extract was saponified (esterified) for 
five (5) minutes at 950C with 3.4ml of the 0.5M KOH in dry methanol. The mixture was then neutralized using 
0.7M HCl. 3ml of the 14% boron triflouride in methanol was later added. The mixture was heated for 5 minutes 
at the temperature of 900C to achieve complete methylation process. The fatty acid methyl esters was thrice 
extracted from the mixture with redistilled n-hexane. The lipid extract was used to profile the fatty acids present 
in the sample using Gas Chromatography and Mass Spectrophotometer and administered to evaluate the dietary 
relevance. 
 
Gas Chromatography and Mass Spectrophotometry 
The content was concentrated to 1ml for gas chromatography analysis and 1µl injected into the injection port of 
GC. The GC equipment used was HP 6890 powered with HP chemstation Rev. A09.01 (1206) software. The 
split ratio will be 20:1, the carrier gas was nitrogen at inlet temperature of 2500C with a column type of HP 
INNOWax and column dimensions of 30m x 0.25mm x 0.25µm. the oven program parameters included initial 
temperature at 600C, first ramping at 120C/minutes for 20minutes, maintained for 2minutes and second ramping 
at 150C/min for 3minutes, maintained for 8minutes. The detector used was FID at 3200C at hydrogen pressure 
22psi and compressed air of 35psi   
 
Results and Discussion  
The gas chromatography analysis of the lipid (hexane-chloroform) extract of A. boonei leaves resulted in sixteen 
peaks as obtained on the chromatogram of the oil. These peaks indicated the presence of sixteen compounds in 
the chloroform-hexane-methanol extract of the leaf. The qualitative and quantitative evaluations of fatty acids in 
the sample revealed the following fatty acids in g/100g of samples caprylic acid (c8:0), 0.005; capric acid (c10:0), 
0.004; lauric acid (c12:0), 0.013; myristic acid (c14:0), 1.216; palmitic acid (c16:0), 30.097; palmitoleic acid 
(c16:1), 2.291; margaric acid (c17:0), 0.072; stearic acid (c18:0), 4.513; oleic acid (c18:1), 6.165; linoleic acid 
(c18:2), 39.735; linolenic acid (c18:3), 14.362; arachidic acid (c20:0), 0.349; arachidonic acid (c20:4), 0.083; 
behenic acid (c22:0), 0.665; erucic acid (c22:1), 0.331; and lignoceric acid (c24:0), 0.100. The extract contained 
the ω-3 fatty acids precursor, -linolenic acid; Linoleic acid, a precursor of ω-6 fatty acids; and arachidonic acid, 
a ω-6 fatty acid, in amounts of 14.362, 39.735 and 0.083 g/100g respectively. By calculation, Alstonia boonei 
leaf had an ω-6 to ω-3 PUFA ratio of 2.77. 
 
GC-MS chromatogram for Alstonia boonei leaf fatty acids profile  
The roles of PUFAs become more important as they are not synthesized in human organism and have 
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to be delivered with food (Ibukun and Oladipo, 2016). The ω-6  and ω-3  eighteen-carbon polyunsaturated fatty 
acids compete for the same metabolic enzymes; thus the ω-6: ω-3 ratio of ingested fatty acids has significant 
influence on the ratio and rate of production of eicosanoids, a group of hormones intimately involved in the 
body's inflammatory and homeostatic processes, which include the prostaglandins, leukotrienes, 
and thromboxanes, among others. Altering this ratio can change the body's metabolic and inflammatory 
state. Metabolites of omega-6 are more inflammatory (esp. arachidonic acid) than those of ω-3. This necessitates 
that ω-6 and ω-3 be consumed in a balanced proportion; healthy ratios of ω-6: ω-3, according to some authors, 
range from 1:1 to 1:4 (an individual needs more omega-3 than omega-6). (Lands, 2005). Other researchers 
believe that ratio 4:1 (when the amount of ω-6 is only 4 times greater than that of ω-3) is already healthy (Daley, 
2004; Simopoulos, 2002). Studies suggested the evolutionary human diet, rich in game animals, seafood, and 
other sources of omega-3, may have provided such a ratio. (Simopoulos, 2003). The importance of the ratio of 
ω-6/ω-3 essential fatty acids as established by comparative studies showed an ω-6: ω-3 ratio under 4:1 may 
contribute to improved health (Simopoulos, 2002). Also, preliminary research indicated that ω-3 fatty acids in 
diets lowered the risk of heart attacks and that ω-6 fatty acids may also reduce the risk of cardiovascular disease 
(Okamoto et al., 2007). 
The result also revealed the presence of Stearic acid (4.513g per 100 g of oil extracts), a saturated fatty 
acid (SFA), which had been shown to have recommendable effects on blood total and low density lipoprotein 
(LDL) cholesterol levels (Mensink, 2005), based on this, it had been shown to alleviate cardiomyopathy (Kris-
Etherton et al., 2005). However, this effects of stearic acid on high density lipoprotein cholesterol (HDL-c) and 
triglyceride levels were inconsistent (Mensink, 2005; Kris-Etherton et al., 2005). Palmitoleic acid is a 
monounsaturated fatty acid resembling saturated fatty acids in its ability to lower LDL-C (Nestel et al., 1994). 
The result also revealed palmitoleic acid (2.291g per 100g), a beneficial fatty acid which has been shown to 
increase insulin sensitivity by suppressing inflammation, as well as inhibit the destruction of insulin-secreting 
pancreatic beta cells (Yang et al., 2011). Oleic acid also has an amount of 6.17 g per 100 g of lipid extract and it 
had been reported as LDL-C lowering fatty acid (Nestel et al., 1994). Palmitic acid, the most common fatty 
acid (saturated) found in animals, plants and microorganisms (Gunstone et al., 2007), occurred in high amount of 
30.10 g per 100 g of oil extract has been reported to reduce LDL as linoleic acid increases (French et al., 2002). 
Lauric, myristic, palmitic and stearic acids had been shown to exert a neutral or hypocholesterolemic effect on 
blood cholesterol levels in experimental animals (Kris-Etherton et al., 2005). However, myristic acid has a 
sufficiently high hydrophobicity to become incorporated into the fatty acyl core of the phospholipid bilayer of 
the plasma membrane of the eukaryotic cell. In this way, myristic acid acts as a lipid anchor in biomembranes. 
In conclusion, the fatty acid profile obtained in this GC–MS analysis revealed promising evidence for 
the effects of the extract of A. boonei to lower the risk of cardiovascular diseases (CVD); and to bring about 
other beneficial pharmacological effect like anti-inflammation and malignant growth suppressing activity. These 
components include essential fatty acids, PUFA, ω-6 and ω-3 which contribute to or ensure improved health. 
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